In today's world, Deva Holding A.S. has become a highly relevant issue that affects people of all ages, genders and nationalities. Therefore, it is important to carefully analyze each aspect related to Deva Holding A.S., since its impact extends to different areas of our daily lives. In this article, we will thoroughly explore the different facets of Deva Holding A.S., from its origin to its current consequences, with the aim of better understanding its influence on society and the life of each individual. Additionally, we will try to offer solutions and recommendations to address the challenges that Deva Holding A.S. currently poses.
The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (February 2020) |
Company type | Pharmaceutical Company |
---|---|
BİST: DEVA | |
Industry | Healthcare |
Founded | September 22, 1958 |
Headquarters | Istanbul, Turkey |
Key people | Mr. Philipp Haas (Chairman and CEO) |
Products | Pharmaceuticals |
Revenue | US$250M |
Number of employees | 2,300 |
Website | www.deva.com.tr |
Pharmaceutical manufacturer Deva Holding A.S. is a Turkish Fortune 500 company with annual revenue of more than US$250 million and a staff of approximately 2,300 across its operations in Turkey, Germany, USA and New Zealand.
Established in 1958, Deva Holding A.S. is Turkey’s second largest pharmaceutical company and is primarily engaged in the production and distribution of pharmaceutical and veterinary products.